ANTIMALARIAL AGENTS AND LUPUS
- 1 February 1994
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 20 (1) , 243-263
- https://doi.org/10.1016/s0889-857x(21)00233-7
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Ocular effects and safety of antimalarial agentsThe American Journal of Medicine, 1988
- Effects of mepacrine and p-bromophenacyl bromide on anti-IgE and phospholipase A2-induced histamine release from human basophilsInflammation Research, 1986
- The side effects of antimalarial drugs indicates a polyamine involvement in both schizophrenia and depressionMedical Hypotheses, 1985
- Quinacrine antagonizes the effects of Na, K-ATPase inhibitors on renal prostaglandin E2 release but not their effects on renin secretionLife Sciences, 1985
- In vitro hexosamine depletion of intact articular cartilage by e‐prostaglandinsArthritis & Rheumatism, 1979
- Ophthalmologic safety of long‐term hydroxychloroquine treatmentArthritis & Rheumatism, 1979
- Quinacrine is a prostaglandin antagonistBiochemical and Biophysical Research Communications, 1977
- Chloroquine Diphosphate in Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 1961
- Rationale for the Treatment of Lupus Erythematosus with Antimalarials1Journal of Investigative Dermatology, 1957
- Lupus Erythematosus and Polymorphous Light EruptionsJournal of Investigative Dermatology, 1953